| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
676,968,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$46.02 - $46.02 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Devitt Blake E |
Director |
– • – |
2016-02-25 |
4 |
B |
$39.17 |
$231,103 |
D/D |
5,900 |
27,965 |
2.39 |
- |
|
| Goff Brian |
EVP and President, Hematology |
• – – |
2016-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,060 |
33,335 |
|
- |
|
| Goff Brian |
EVP and President, Hematology |
• – – |
2016-02-15 |
4 |
D |
$39.00 |
$20,787 |
D/D |
(533) |
32,827 |
|
- |
|
| Hombach Robert J. |
EVP, CFO and COO |
• – – |
2016-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
6,956 |
116,981 |
|
- |
|
| Hombach Robert J. |
EVP, CFO and COO |
• – – |
2016-02-15 |
4 |
D |
$39.00 |
$158,574 |
D/D |
(4,066) |
114,095 |
|
- |
|
| Mccoy John A. |
SVP and Controller |
• – – |
2016-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
329 |
14,440 |
|
- |
|
| Mccoy John A. |
SVP and Controller |
• – – |
2016-02-15 |
4 |
D |
$39.00 |
$8,112 |
D/D |
(208) |
14,289 |
|
- |
|
| Glasspool John |
See Remarks |
• – – |
2016-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
563 |
25,352 |
|
- |
|
| Glasspool John |
See Remarks |
• – – |
2016-02-15 |
4 |
D |
$39.00 |
$13,767 |
D/D |
(353) |
25,094 |
|
- |
|
| Leonardi Jacopo |
EVP and President, Immunology |
• – – |
2016-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
360 |
27,847 |
|
- |
|
| Leonardi Jacopo |
EVP and President, Immunology |
• – – |
2016-02-15 |
4 |
D |
$39.00 |
$8,112 |
D/D |
(208) |
27,665 |
|
- |
|
| Hantson Ludwig |
President and CEO |
• • – |
2016-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
7,973 |
220,498 |
|
- |
|
| Hantson Ludwig |
President and CEO |
• • – |
2016-02-15 |
4 |
D |
$39.00 |
$243,282 |
D/D |
(6,238) |
217,612 |
|
- |
|
| Baxter International Inc |
10% Owner |
– – • |
2016-02-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(37,573,040) |
94,329,679 |
|
- |
|
| Glasspool John |
See Remarks |
• – – |
2015-12-03 |
4 |
D |
$34.98 |
$61,075 |
D/D |
(1,746) |
24,975 |
|
- |
|
| Leonardi Jacopo |
EVP and President, Immunology |
• – – |
2015-12-03 |
4 |
D |
$34.98 |
$29,208 |
D/D |
(835) |
27,505 |
|
- |
|
| Rosa-Bjorkeson Dagmar |
EVP and President, Biosimilars |
• – – |
2015-12-01 |
4/A |
D |
$34.63 |
$238,705 |
D/D |
(6,893) |
56,737 |
|
- |
|
| Rosa-Bjorkeson Dagmar |
EVP and President, Biosimilars |
• – – |
2015-12-01 |
4 |
D |
$34.63 |
$238,705 |
D/D |
(6,893) |
11,610 |
|
- |
|
| Meek David D. |
EVP and President, Oncology |
• – – |
2015-09-02 |
4 |
D |
$35.03 |
$27,709 |
D/D |
(791) |
24,277 |
|
- |
|
| Mccoy John A. |
SVP and Controller |
• – – |
2015-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
91 |
14,248 |
|
- |
|
| Glasspool John |
See Remarks |
• – – |
2015-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
155 |
26,361 |
|
- |
|
| Goff Brian |
EVP and President, Hematology |
• – – |
2015-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
292 |
32,600 |
|
- |
|
| Hombach Robert J. |
EVP, CFO and COO |
• – – |
2015-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,894 |
113,451 |
|
- |
|
| Hantson Ludwig |
President and CEO |
• • – |
2015-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,144 |
217,221 |
|
- |
|
| Leonardi Jacopo |
EVP and President, Immunology |
• – – |
2015-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
100 |
27,977 |
|
- |
|
125 Records found
|
|
Page 4 of 5 |
|
|
